STOCK TITAN

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will host a conference call on April 19, 2022, at 8:30 a.m. (ET) to discuss its first-quarter results. The call will be led by Joseph J. Wolk, Chief Financial Officer, and Jessica Moore, Vice President of Investor Relations, along with other executives.

Investors can access the call via webcast at www.investor.jnj.com, with a replay available three hours post-call. The press release will be issued at 6:45 a.m. (ET) on the same day.

Positive
  • None.
Negative
  • None.

NEW BRUNSWICK, N.J., March 15, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 19th to review first-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
  • By telephone: for both "listen-only" participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on May 3rd. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13727645.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
  • Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the second-quarter date of Tuesday, July 19th, 2022.
About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

(PRNewsfoto/Johnson & Johnson)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-host-investor-conference-call-on-first-quarter-results-301502862.html

SOURCE Johnson & Johnson

FAQ

When will Johnson & Johnson's first-quarter results conference call take place?

The conference call is scheduled for April 19, 2022, at 8:30 a.m. (ET).

Who will host the Johnson & Johnson conference call on April 19, 2022?

Joseph J. Wolk, Chief Financial Officer, and Jessica Moore, Vice President of Investor Relations will host the call.

How can I access Johnson & Johnson's conference call on April 19, 2022?

You can access the call via webcast at www.investor.jnj.com or by telephone at 877-869-3847 for U.S. participants.

Is there a replay available for Johnson & Johnson's conference call?

Yes, a replay will be available until approximately 12:00 a.m. on May 3, 2022.

What time will the press release for Johnson & Johnson's conference call be available?

The press release will be available at 6:45 a.m. (ET) on April 19, 2022.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

347.83B
2.41B
0.09%
73.15%
0.73%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK